Monthly Archives: November 2007

Molecular therapy and surgery combined in GIST

For most cancers, the combined use of multiple different types of therapy is the most effective approach. Over the last several years, we have applied this philosophy to GIST. In this article, I will review our current understanding of multimodality therapy for both primary GIST and metastatic GIST. The gold standard of therapy for primary GIST is surgery.

By |2019-12-30T11:38:04-05:00November 29th, 2007|News, Research|

Member Story – Judi Lifton

Judi Lifton had no idea what she was getting into when she tried to get compassionate use of AMN107 for her partner, Leland Emerson. He could not qualify for the trial as he had already taken Gleevec, Sutent and AMG706. Being ever the vigilant caregiver, Judi began the process which would end up consuming all of her time and possibly her sanity.

By |2015-03-10T15:12:00-04:00November 11th, 2007|Member Stories|

Looking for new ways to fight GIST

In 1991, Joseph Schlessinger, PhD, and Axel Ullrich, PhD, co-founded a small bio-tech company. Taking the first letter of each of their names, they named the company Sugen. Sugen was considered to be one of [...]

By |2019-12-30T11:45:46-05:00November 3rd, 2007|News|
Go to Top